Implantable carotid sinus baroreflex device for the treatment of drug-resistant hypertension
Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)
Record ID 32015000981
English
Authors' recommendations:
Currently there is a lack of clinical and cost-effectiveness evidence to support the use of the baroreflex stimulation to reduce hypertension. It should be noted that the Baroreflex Rheos device has been superseded by the Barostim neo, which is not available in Australia. A large, prospective RCT on the Barostim neo device is due for completion in 2015, the results of which, if favourable, will be identified by horizon scanning activities. Therefore it is recommended that no further research on behalf of HealthPACT is warranted at this time.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www.health.qld.gov.au/healthpact/docs/updates/WP066_update.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Baroreflex
- Carotid Sinus
- Blood Pressure
- Hypertension
Contact
Organisation Name:
Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
Contact Address:
ASERNIP-S 24 King William Street, Kent Town SA 5067 Australia Tel: +61 8 8219 0900
Contact Name:
racs.asernip@surgeons.org
Contact Email:
racs.asernip@surgeons.org
Copyright:
<p>Australian Safety and Efficacy Register of New Interventional Procedures - Surgical</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.